ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Tightens Monitoring, Upgrades Staff Training In Attempts To Improve Management Of Contracts

January 9, 1981

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

An Unusual Week Of Deals In Oncology: Alliances, Sales, and Dramatic Moves

November 13, 1998

Five New Members Appointed To The National Cancer Advisory Board

July 8, 2011

National Academy Of Sciences To form Cancer Policy Board At NCI’s Request

August 16, 1996

Will Latest Report By Rosenberg Stir Up Critics? Some DCT Board Members Defend the Press

April 10, 1987